Bristol-Myers CEO: We're 'one step closer to creating that great company' with Celgene

Indonesia Berita Berita

Bristol-Myers CEO: We're 'one step closer to creating that great company' with Celgene
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 CNBC
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 72%

Celgene brings to Bristol-Myers five late-stage products that could be approved in the near term, Caforio said.

Bristol-Myers Squibb CEO Giovanni Caforio told CNBC on Friday the company is"one step closer to creating that great company" after shareholders greenlit a $74 billion takeover of Celgene.

"When the two companies come together, we'll have two growing businesses," Caforio said in an interview with "Mad Money's" Jim Cramer."We're going to be able to launch six new medicines, potentially, in the next two years. It's going to be a great company, [will] create value for shareholders, [and will be] very good for patients."

Celgene is also a leader, he added, in treatments for multiple myeloma, a cancer that attacks the plasma cells that create antibodies to fight infections.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

CNBC /  🏆 12. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Bristol-Myers shareholders approve drugmaker's $74 billion deal with CelgeneBristol-Myers shareholders approve drugmaker's $74 billion deal with Celgene
Baca lebih lajut »

Bristol-Myers says shareholders vote to approve Celgene takeoverBristol-Myers says shareholders vote to approve Celgene takeoverBristol-Myers Squibb Co's shareholders voted to approve the drugmaker'...
Baca lebih lajut »

Bristol-Myers shareholders approve drugmaker's $74 billion deal with CelgeneBristol-Myers shareholders approve drugmaker's $74 billion deal with Celgene
Baca lebih lajut »

Bristol-Myers says shareholders vote to approve Celgene takeoverBristol-Myers says shareholders vote to approve Celgene takeoverBristol-Myers Squibb Co's shareholders voted to approve the drugmaker'...
Baca lebih lajut »

Here’s one way to tell if a company is overpaying its CEOHere’s one way to tell if a company is overpaying its CEOU.S. companies that use non-standard numbers to calculate executive compensation are overpaying their top managers, according to a new research report.
Baca lebih lajut »

Disney CEO Bob Iger says he will step down in 2021, a succession plan is formingDisney CEO Bob Iger says he will step down in 2021, a succession plan is formingDisney CEO Bob Iger said that he is definitely stepping down from his post at the company in 2021.
Baca lebih lajut »

Exclusive: Trump eyeing stepped-up Venezuela sanctions for foreign companies - BoltonExclusive: Trump eyeing stepped-up Venezuela sanctions for foreign companies - BoltonWATCH: Trump is eyeing 'secondary sanctions' on Venezuela that would hit companies from other countries who do business with Maduro's government, national security adviser Bolton said
Baca lebih lajut »

Disney CEO Iger gives three reasons why the company's streaming service will be a successDisney CEO Iger gives three reasons why the company's streaming service will be a successDisney Chairman and CEO Bob Iger explained that he believes customers will flock to Disney+ thanks to a combination of unique factors.
Baca lebih lajut »



Render Time: 2025-03-15 18:01:56